Samia Melaabi

920 citations

22 papers · 456 indexed · h-index 10

Co-authors: François‐Clément Bidard Jean‐Yves Pierga Luc Cabel Céline Callens Guillaume Bataillon Anne Vincent‐Salomon Ivan Bièche Marc‐Henri Stern
Topics: Cancer Genomics and Diagnostics (10 papers)Lung Cancer Treatments and Mutations (10 papers)Lung Cancer Research Studies (6 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Cancer Research Oncogene Annals of Oncology
Partner nations: France Switzerland Italy

In The Last Decade

Samia Melaabi

21 papers receiving 450 citations

Peers

Countries citing papers authored by Samia Melaabi

Since Specialization

Citations

This map shows the geographic impact of Samia Melaabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samia Melaabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samia Melaabi more than expected).

Fields of papers citing papers by Samia Melaabi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samia Melaabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samia Melaabi. The network helps show where Samia Melaabi may publish in the future.

Co-authorship network of co-authors of Samia Melaabi

This figure shows the co-authorship network connecting the top 25 collaborators of Samia Melaabi. A scholar is included among the top collaborators of Samia Melaabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samia Melaabi. Samia Melaabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood 2023 ·Clinical Genetics ·(unknown),Virginie Moncoutier,(unknown),(unknown),(unknown),Mélanie Pagès,Julien Masliah‐Planchon,(unknown),Samia Melaabi,Céline Callens,Ivan Bièche,(unknown),Antoine De Pauw,Claire Saule,Emmanuelle Mouret‐Fourme,Marion Gauthier‐Villars,Bruno Buecher,Chrystelle Colas,Dominique Stoppa‐Lyonnet,Lisa Golmard	2
2	Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report 2022 ·Lung Cancer ·(unknown),L. Zemoura,(unknown),Catherine Daniel,Samia Melaabi,Céline Callens,(unknown),Ivan Bièche,Nicolas Girard	5
3	A single droplet digital PCR for ESR1 activating mutations detection in plasma 2020 ·Oncogene ·Emmanuelle Jeannot,Lauren Darrigues,Marc Michel,Marc‐Henri Stern,Jean‐Yves Pierga,Aurore Rampanou,Samia Melaabi,(unknown),Ivan Bièche,Anne Vincent‐Salomon,(unknown),(unknown),Nicolas Epaillard,Luc Cabel,François‐Clément Bidard,Charlotte Proudhon	42
4	Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases 2020 ·Lung Cancer ·(unknown),Jean‐Baptiste Assié,I. Monnet,Marie-Ange Massiani,(unknown),S. Friard,(unknown),Anne-Cécile Métivier,C. Chouaïd,L. Zemoura,Élisabeth Longchampt,Céline Callens,Samia Melaabi,Louis‐Jean Couderc,H. Doubre	39
5	Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers 2020 ·Journal of Hematology & Oncology ·Florence Coussy,Rania El Botty,(unknown),(unknown),Laetitia Fuhrmann,Adrien Briaux,Leanne de Koning,(unknown),Élodie Montaudon,Ludivine Morisset,Léa Huguet,Laura Sourd,Pierre Painsec,Sophie Château‐Joubert,Thibaut Larcher,Sophie Vacher,Samia Melaabi,Anne Vincent‐Salomon,Elisabetta Marangoni,Ivan Bièche	43
6	Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC 2020 ·JTO Clinical and Research Reports ·Catherine Daniel,Céline Callens,Samia Melaabi,Ivan Bièche,Nicolas Girard	7
7	ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer 2019 ·Journal of Breast Cancer ·(unknown),Samia Melaabi,Jean‐Yves Pierga,François‐Clément Bidard,Luc Cabel	5
8	MA03.09 Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers 2019 ·Journal of Thoracic Oncology ·(unknown),I. Monnet,Marie-Ange Massiani,Jean‐Baptiste Assié,(unknown),S. Friard,(unknown),(unknown),C. Chouaïd,L. Zemoura,Élisabeth Longchampt,Samia Melaabi,L.J. Couderc,H. Doubre	2
9	Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project 2019 ·Lung Cancer ·Michèle Beau‐Faller,Erwan Pencreach,Charlotte Leduc,Hélène Blons,Jean‐Philippe Merlio,Pierre‐Paul Bringuier,Florence de Fraipont,Fabienne Escande,Antoinette Lemoine,L’Houcine Ouafik,Marc G. Denis,Paul Hofman,Roger Lacave,Samia Melaabi,Alexandra Langlais,Pascale Missy,Franck Morin,Denis Moro‐Sibilot,Fabrice Barlési,J. Cadranel	13
10	High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study 2019 ·Journal of Thoracic Oncology ·Simon Baldacci,Martin Figeac,Martine Antoine,(unknown),Zoulika Kherrouche,Philippe Jamme,Marie‐Christine Copin,David Tulasne,Isabelle Nanni,Michèle Beau‐Faller,Samia Melaabi,Guénaëlle Levallet,Élisabeth Quoix,Denis Moro‐Sibilot,S. Friard,Pascale Missy,Fabrice Barlési,Jacques Cadranel,Alexis B. Cortot	16
11	ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics 2019 ·Oncogene ·Nicolas Kiavué,Luc Cabel,Samia Melaabi,Guillaume Bataillon,Céline Callens,Florence Lerebours,Jean‐Yves Pierga,François‐Clément Bidard	74
12	P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study 2019 ·Journal of Thoracic Oncology ·Simon Baldacci,Martin Figeac,Martine Antoine,(unknown),Zoulika Kherrouche,Philippe Jamme,M.C. Copin,David Tulasne,(unknown),(unknown),Samia Melaabi,(unknown),(unknown),Denis Moro‐Sibilot,S. Friard,(unknown),Fabrice Barlési,J.F. Cadranel,Alexis B. Cortot	2
13	ESR1 mutations: a new biomarker in breast cancer 2019 ·Expert Review of Molecular Diagnostics ·(unknown),François‐Clément Bidard,Céline Callens,Samia Melaabi,Emmanuelle Jeannot,Jean‐Yves Pierga,Luc Cabel	46
14	Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non–small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2) 2018 ·Clinical Lung Cancer ·Michèle Beau‐Faller,Matthieu Texier,Hélène Blons,Nicolas Richard,Fabienne Escande,Samia Melaabi,Sarab Lizard,Florence de Fraipont,Élisabeth Longchampt,Franck Morin,Gérard Zalcman,Jean‐Pierre Pignon,J. Cadranel	2
15	Abstract 4599: Detecting MSI phenotype in circulating blood DNA 2018 ·Cancer Research ·Marc‐Henri Stern,(unknown),Ivan Bièche,Samia Melaabi,Luc Cabel,Bruno Buecher,Jean‐Yves Pierga,François‐Clément Bidard,Charlotte Proudhon	2
16	Réponse à l’immunothérapie des cancers bronchiques non à petites cellules (CBNPC) présentant des mutations induisant un épissage de l’exon 14 du gène MET : à propos de 4 cas 2018 ·Revue des Maladies Respiratoires ·H. Doubre,(unknown),I. Monnet,Anne-Cécile Métivier,S. Friard,(unknown),(unknown),L. Zemoura,(unknown),Samia Melaabi,L.J. Couderc	1
17	Ultrasensitive detection of EGFR T790M mutation by droplet digital PCR (ddPCR) in TKI naïve non-small cell lung cancer (NSCLC) harboring EGFR mutation: Results of the nationwide program Biomarkers France of the French Cooperative Thoracic Intergroup (IFCT) 2017 ·Annals of Oncology ·Charlotte Leduc,Erwan Pencreach,J.P. Merlio,(unknown),Florence de Fraipont,Fabienne Escande,(unknown),(unknown),Hélène Blons,Marc G. Denis,Paul Hofman,Roger Lacave,Samia Melaabi,Alexandra Langlais,(unknown),Franck Morin,Fabrice Barlési,Denis Moro‐Sibilot,J. Cadranel,Michèle Beau‐Faller	0
18	Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations 2017 ·Familial Cancer ·Bruno Buecher,Antoine De Pauw,Louis Bazire,Claude Houdayer,Alice Fiévet,Virginie Moncoutier,(unknown),Samia Melaabi,(unknown),Lisa Golmard	6
19	Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 2017 ·Modern Pathology ·(unknown),Emmanuelle Menet,Jean‐Christophe Tille,Marick Laé,Laetitia Fuhrmann,Claire Bonneau,(unknown),Samia Melaabi,Charlotte K.Y. Ng,Caterina Marchiò,Roman Rouzier,Ivan Bièche,Anne Vincent‐Salomon	50
20	Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR 2017 ·Clinical Chemistry ·Charles Decraene,Amanda Bortolini Silveira,François‐Clément Bidard,Audrey Vallée,Marc Michel,Samia Melaabi,Anne Vincent‐Salomon,Adrien Saliou,Alexandre Houy,Maud Milder,Olivier Lantz,Marc Ychou,Marc G. Denis,Jean‐Yves Pierga,Marc‐Henri Stern,Charlotte Proudhon	43

About Samia Melaabi

Samia Melaabi is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 22 papers that have together received 456 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Cancer Research (199 citations), Oncology (200 citations) and Pathology and Forensic Medicine (120 citations). Samia Melaabi has collaborated with scholars based in France, Switzerland and Italy. Frequent co-authors include François‐Clément Bidard, Jean‐Yves Pierga, Luc Cabel, Céline Callens, Guillaume Bataillon, Anne Vincent‐Salomon, Ivan Bièche, Marc‐Henri Stern, Charlotte Proudhon and Emmanuelle Jeannot. Their work appears in journals such as Cancer Research, Oncogene and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact